Ohio State is at the forefront of pioneering neurological therapies and technologies. These advanced treatments are providing innovative, effective therapies for patients with physical and mental conditions.
Ohio State Behavioral Health is part of The Ohio State University Wexner Medical Center’s nationally recognized neuroscience program. We can offer these modern, effective neurotherapies:
Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation (TMS) therapy is a Federal Drug Administration (FDA)-approved non-drug treatment for depression and other conditions. TMS uses magnetic pulses to stimulate areas of the brain thought to control mood. These areas are underactive in patients who are experiencing depression. TMS can be an option for patients who have not benefited from antidepressant medication or other therapies. TMS can provide effective treatment without the side effects that may accompany medications.
TMS treatment sessions are conducted on an outpatient basis at Ohio State Harding Hospital. Each session takes less than an hour. Treatments are typically scheduled five days a week for approximately four to six weeks. Patients are awake and alert during treatment and able to resume normal activities upon leaving therapy. Call to schedule an evaluation.
Electroconvulsive therapy (ECT) is a very effective and generally safe treatment for depression and other conditions. The patients who receive ECT usually have not responded well to antidepressant medications or are unable to take them for a medical reason.
ECT is conducted while the patient is under anesthesia. ECT uses electricity to trigger a seizure. The patient receives medicine to prevent the seizure from spreading throughout the body. Patients generally awaken several minutes after ECT and do not remember the treatment. According to the National Institute of Mental Health, 80-90% of people with severe depression improve dramatically with ECT.
Ketamine Infusion Therapy
Infusion therapy can be a rapid-acting treatment for depression. Ketamine works directly with brain receptors. Unlike oral antidepressants, which can take weeks to have an effect, ketamine may work almost immediately.
Intranasal Esketamine Treatment
FDA-approved intranasal esketamine (Spravato) is for treatment-resistant depression in adults. This medication is used with a traditional antidepressant and is offered only in a clinic setting.
Learn more about brain and spine neurological conditions at The Ohio State University Wexner Medical Center.